TITLE

TOPICAL CHELATION THERAPY FOR VARICOSE PIGMENTATION

AUTHOR(S)
Myers, Harvey L.
PUB. DATE
January 1966
SOURCE
Angiology;Jan1966, Vol. 17 Issue 1, p66
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Focuses on the efficacy of chelation therapy for varicose pigmentation. Causes of the varicose pigmentation; Safety of the chelating agent disodium ethylene diamide tetraaacetic acid; Effect of chelation on melanin pigment formation.
ACCESSION #
16346962

 

Related Articles

  • chelation therapy:. Huber, Jeffrey T.; Gillaspy, Mary L. // Encyclopedic Dictionary of AIDS-Related Terminology;2000, p50 

    A definition of the term "chelation therapy" is presented. It refers to therapy of heavy metal poisoning. This therapeutic method uses agents which sequester the poisonous metal from organs or tissues and binds it firmly within the ring structure of a new compound which can be eliminated from...

  • EXPLORING THE ALTERNATIVES. Perry, Patrick // Saturday Evening Post;May/June2005, Vol. 277 Issue 3, p74 

    Provides an overview of the study Trial to Assess Chelation Therapy, which is led by Gervasio Lamas, to determine the potential of chelation therapy in heart disease. Factors which contributed to the growth of chelation therapy as alternative medicine; Benefits of chelation therapy; Details of...

  • Case Study: A Comprehensive Approach to Pseudo Fibromyalgia. Hedberg, Nikoas R. // Original Internist;Mar2009, Vol. 16 Issue 1, p20 

    The article describes the case of a woman who was diagnosed with pseudo fibromyalgia of 35 years duration and achieved complete symptom resolution after Dimercaptosuccinic acid (DMSA) oral chelation as well as dietary modification and dental amalgam were removed. She had high levels of mercury...

  • Brief Report: Lead Poisoning From Ingestion of a Toy Necklace—Oregon, 2003. VanArsdale, J. L.; Horowitz, B. Z.; Merritt, T. A.; Peddycord, D. W.; Severson, E.; Moore, K. M.; Pusel, N. J.; Leiker, R. D.; Zeal, B. R.; Scott, M. J.; Kohn, M. A. // JAMA: Journal of the American Medical Association;7/28/2004, Vol. 292 Issue 4, p430 

    Describes an investigation into lead poisoning in a boy from Oregon who swallowed a medallion pendant from a necklace sold in a toy vending machine. Symptoms; Hospital treatment, including an abdominal radiograph and endoscopy; Admission to the pediatric intensive care unit three days later for...

  • Is living proof enough? Yu, Winifred // Natural Health;Apr99, Vol. 29 Issue 3, p64 

    Provides information on chelation, a process first developed to remove metals from the body. Factors that may explain the success of chelation; Increase in the body's free radical population by too many metallic ions in the body; Criticisms and praises for the process.

  • Successful treatment of extreme acute lead intoxication. Mikler, J.; Banovcin, P.; Jesenak, M.; Hamzikova, J.; Statelova, D. // Toxicology & Industrial Health;Mar2009, Vol. 25 Issue 2, p137 

    Severe acute lead intoxications are rare and are associated with accidental or purposeful ingestion. There were only few cases of severe to fatal poisonings reported in literature in children. We report a case of acute lead intoxication in a child with extremely high lead blood level of 20.4...

  • Lead toxicosis of captive vultures: case description and responses to chelation therapy. Pikula, Jiri; Hajkova, Pavlina; Bandouchova, Hana; Bednarova, Ivana; Adam, Vojtech; Beklova, Miroslava; Kral, Jiri; Ondracek, Karel; Osickova, Jitka; Pohanka, Miroslav; Sedlackova, Jana; Skochova, Hana; Sobotka, Jakub; Treml, Frantisek; Kizek, Rene // BMC Veterinary Research;2013, Vol. 9 Issue 1, p1 

    Background: Lead, a serious threat for raptors, can hamper the success of their conservation. This study reports on experience with accidental lead intoxication and responses to chelation therapy in captive Cinereous (Aegypius monachus) and Egyptian (Neophron percnopterus) Vultures. Results:...

  • Iron Chelation Therapy for Myelodysplastic Syndrome: If and When. Tefferi, Ayalew // Mayo Clinic Proceedings;Feb2006, Vol. 81 Issue 2, p197 

    The article comments on the use oral chelating agent for treatment of myelodysplastic syndrome (MDS). The iron chelating agent approved by the U.S. Food and Drug Administration was subcutaneously infused deferoxamine. Most patients with MDS are dependent on red blood cell transfusions and are...

  • The copper chelator, D-penicillamine, does not attenuate MPTP induced dopamine depletion in mice. Youdim, M. B. H.; Grünblatt, E.; Mandel, S. // Journal of Neural Transmission;Feb2007, Vol. 114 Issue 2, p205 

    In MPTP (N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) and 6-hydroxydopamine induced dopaminergic neurotoxicity and Parkinson’s disease iron accumulates in substantia nigra pars compacta which has been suggested to participate in oxidative stress induced neurodegeneration. Pretreatment...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics